T Cell News and Research

Latest T Cell News and Research

Scientists find link between antimicrobial chemicals and antibiotic-resistance genes in microbes

Antibiotic-resistant bacteria, known as "superbugs," pose a major public health threat.

7 Sep 2016

Fraunhofer researchers plan to use electron beams to remove germs from tissue transplants

Medical products, packaging and food can be safely and efficiently sterilized with electron beams.

7 Sep 2016

Many parents follow outdated advice that may worsen child's recovery from concussion, survey reveals

A new national survey, commissioned by UCLA Health, reveals that a vast majority of parents may be following outdated advice when caring for a child with a concussion, and it could be making their child's symptoms worse.

7 Sep 2016

Researchers find genomic material from Zika virus in tears

Researchers have found that Zika virus can live in eyes and have identified genetic material from the virus in tears, according to a study from Washington University School of Medicine in St. Louis.

7 Sep 2016

Tumor microenvironment acts as source of resistance to cancer therapies

Researchers at Bellvitge Biomedical Research Institute have published a new Oncotarget work which highlights the importance of the tumor environment as a source of resistance to treatment in colorectal cancer, the fourth most common cancer and the leading cause of cancer death worldwide.

7 Sep 2016

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Two studies appearing in the September 6 issue of JAMA examine the effectiveness of nasal sprays to reduce the frequency and duration of nosebleeds caused by hereditary hemorrhagic telangiectasia (HHT), an inherited condition characterized by abnormal blood vessels which are delicate and prone to bleeding.

6 Sep 2016

Whole brain radiotherapy offers no quality-of-life benefit in lung cancer patients with brain metastases

People with the most common type of lung cancer whose disease has spread to the brain could be spared potentially harmful whole brain radiotherapy, according to new research published in The Lancet.

6 Sep 2016

New drug holds potential for treating advanced mastocytosis

Most people have never heard of mastocytosis. It's a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too.

6 Sep 2016

TUM researchers use luminous jellyfish proteins to investigate cardiac rhythm dysfunctions

Cell models from stem cells serve an ever-increasing role in research of cardiac dysfunction. Researchers at the Technical University of Munich have succeeded in producing cells which offer new insights into properties of the heart.

6 Sep 2016

Nanomechanical microcantilevers can quickly detect mutations in patients with malignant melanoma

Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology.

6 Sep 2016

Research findings pave way to better tailored treatment for oesophageal cancer

Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments tailored to patients' disease for the first time.

6 Sep 2016

Researchers use unique computational approach to identify promising drug leads for heart diseases

Using a unique computational approach to rapidly sample, in millisecond time intervals, proteins in their natural state of gyrating, bobbing, and weaving, a research team from UC San Diego and Monash University in Australia has identified promising drug leads that may selectively combat heart disease, from arrhythmias to cardiac failure.

6 Sep 2016

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were normal or underweight.

6 Sep 2016

HIF-2 inhibitors could be promising target to combat kidney cancer

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.

6 Sep 2016

T Cell News and Research

Latest T Cell News and Research

Scientists find link between antimicrobial chemicals and antibiotic-resistance genes in microbes

Fraunhofer researchers plan to use electron beams to remove germs from tissue transplants

Many parents follow outdated advice that may worsen child's recovery from concussion, survey reveals

Researchers find genomic material from Zika virus in tears

Tumor microenvironment acts as source of resistance to cancer therapies

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Whole brain radiotherapy offers no quality-of-life benefit in lung cancer patients with brain metastases

New drug holds potential for treating advanced mastocytosis

TUM researchers use luminous jellyfish proteins to investigate cardiac rhythm dysfunctions

Nanomechanical microcantilevers can quickly detect mutations in patients with malignant melanoma

Research findings pave way to better tailored treatment for oesophageal cancer

Researchers use unique computational approach to identify promising drug leads for heart diseases

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

HIF-2 inhibitors could be promising target to combat kidney cancer

Novel technique offers new insights into growth variation across single cells

Scientists discover brain circuit crucial to sleep-wake cycle

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

JMU scientists crystallize new inhibitory antibodies targeting sclerostin

Discovery of signalling pathway could pave way for developing treatments targeting T-ALL leukaemia

New discovery could potentially lead to treatments for Crohn's disease

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in